Diabetes Care. 2024;47(9):1622-1629.
Genome-Wide Polygenic Risk Score Predicts Incident Type 2 Diabetes in Women With History of Gestational Diabetes.
제1저자 최재원 · 교신저자 곽수헌
소속 (15)
- Division of Data Science Research, Innovative Biomedical Technology Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Preventive Medicine (Biostatistics), Northwestern University Feinberg School of Medicine, Chicago, IL.
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.
- Programs in Metabolism and Medical & Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA.
- Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
- Department of Medicine, Harvard Medical School, Boston, MA.
- Metabolism Program, The Broad Institute of MIT and Harvard, Cambridge, MA.
- Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA.
- Department of Internal Medicine, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
- Department of Genomic Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Abstract
OBJECTIVE Women with a history of gestational diabetes mellitus (GDM) are at increased risk of developing type 2 diabetes (T2D). It remains unclear whether genetic information improves prediction of incident T2D in these women.
RESEARCH DESIGN AND METHODS Using five independent cohorts representing four different ancestries (n = 1,895), we investigated whether a genome-wide T2D polygenic risk score (PRS) is associated with increased risk of incident T2D. We also calculated the area under the receiver operating characteristics curve (AUROC) and continuous net reclassification improvement (NRI) following the incorporation of T2D PRS into clinical risk models to assess the diagnostic utility.
RESULTS Among 1,895 women with previous history of GDM, 363 (19.2%) developed T2D in a range of 2 to 30 years. T2D PRS was higher in those who developed T2D (-0.08 vs. 0.31, P = 2.3 × 10-11) and was associated with an increased risk of incident T2D (odds ratio 1.52 per 1-SD increase, 95% CI 1.05-2.21, P = 0.03). In a model that includes age, family history of diabetes, systolic blood pressure, and BMI, the incorporation of PRS led to an increase in AUROC for T2D from 0.71 to 0.74 and an intermediate improvement of NRI (0.32, 95% CI 0.15-0.49, P = 3.0 × 10-4). Although there was variation, a similar trend was observed across study cohorts.
CONCLUSIONS In cohorts of GDM women with diverse ancestry, T2D PRS was significantly associated with future development of T2D. A significant but small improvement was observed in AUROC when T2D PRS was integrated into clinical risk models to predict incident T2D.
© 2024 by the American Diabetes Association.
Conflict of interest statement
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
그 밖의 정보
- 출판 형태
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- 저널
- Diabetes care · eISSN 1935-5548
- MeSH
- Humans · Female · Diabetes, Gestational* / genetics / epidemiology · Diabetes Mellitus, Type 2* / genetics / epidemiology · Pregnancy · Adult · Genome-Wide Association Study* · Middle Aged · Risk Factors · Multifactorial Inheritance / genetics · Genetic Risk Score
- 연구비
- NICHD NIH HHS R01 HD034242 · Korean Ministry of Science and ICT RS-2023-00262002 · NICHD NIH HHS R01 HD034243 · NHGRI NIH HHS U01HG011723 · NIDDK NIH HHS R01 DK117491 · NHGRI NIH HHS U01 HG011723 · Korean Ministry of Food and Drug Safety grant 23212MFDS202 · NIDDK NIH HHS U01DK094830 · Eunice Kennedy Shriver National Institute of Child Health and Human Development R01-HD-34242 · NIDDK NIH HHS U01 DK094830
- 참고문헌
- 40편